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Abstract
The protein product of the myxovirus resistance 2 (MX2) gene restricts HIV-1 and simian retroviruses. We demonstrate
thatMX2 evolved adaptively in mammals with distinct sites representing selection targets in distinct branches; selection
mainly involved residues in loop 4, previously shown to carry antiviral determinants. Modeling data indicated that
positively selected sites form a continuous surface on loop 4, which folds into two antiparallel a-helices protruding from
the stalk domain. A population genetics–phylogenetics approach indicated that the coding region ofMX2mainly evolved
under negative selection in the human lineage. Nonetheless, population genetic analyses demonstrated that natural
selection operated onMX2 during the recent history of human populations: distinct selective events drove the frequency
increase of two haplotypes in the populations of Asian and European ancestry. The Asian haplotype carries a suscep-
tibility allele for melanoma; the European haplotype is tagged by rs2074560, an intronic variant. Analyses performed on
three independent European cohorts of HIV-1-exposed seronegative individuals with different geographic origin and
distinct exposure route showed that the ancestral (G) allele of rs2074560 protects from HIV-1 infection with a recessive
effect (combined P=1.55 104). The same allele is associated with lower in vitro HIV-1 replication and increasesMX2
expression levels in response to IFN-a. Data herein exploit evolutionary information to identify a novel host determinant
of HIV-1 infection susceptibility.
Key words: MX2, adaptive evolution, positive selection, HIV-1 infection.
Introduction
The protein product of the human myxovirus resistance 2
(MX2, also known as MxB) gene was recently shown to act as
an inhibitor of HIV-1 infection (Goujon et al. 2013; Kane et al.
2013; Liu, Pan, et al. 2013). MX2 blocks HIV-1 replication at a
late postentry step by decreasing nuclear accumulation and
chromosomal integration of nascent viral DNA (Goujon et al.
2013; Kane et al. 2013; Liu, Pan, et al. 2013). HIV-1 capsid
mutations that alter the nuclear import pathway used by
the virus relieve the inhibition operated by MX2 (Goujon
et al. 2013; Kane et al. 2013; Liu, Pan, et al. 2013). Thus,
MX2 is thought to target the capsid and to interact with
other cellular proteins such as peptidylprolyl isomerase A
(cyclophilin A) to block HIV-1 nuclear import (Liu, Pan,
et al. 2013).
MX2 and its paralog MX1 (or MxA) belong to the dyna-
min-like large GTPase superfamily and share a common struc-
ture consisting of an N-terminal GTPase domain and a
C-terminal stalk connected by a bundle signaling element
(fig. 1) (Haller and Kochs 2011). The protein products of
the two genes display high identity but different cellular lo-
calization and diverse antiviral specificity. MX1 can restrict a
wide variety of viruses including orthomyxoviruses (e.g., influ-
enza and Thogoto), bunyaviruses (e.g., La Crosse and rift valley
viruses), and hepatitis B virus (Haller and Kochs 2011).
Conversely, MX2 is known to counteract retroviruses only
(Goujon et al. 2013; Kane et al. 2013; Liu, Pan, et al. 2013),
 The Author 2014. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution. All rights reserved. For permissions, please
e-mail: journals.permissions@oup.com
2402 Mol. Biol. Evol. 31(9):2402–2414 doi:10.1093/molbev/msu193 Advance Access publication June 14, 2014
 at U
niversity degli Studi M
ilano on D
ecem
ber 29, 2015
http://m
be.oxfordjournals.org/
D
ow
nloaded from
 
AB
C
FIG. 1. Adaptive evolution of MX2 in mammals. (A) Schematic representation of the domain structure of MX2 (cyan, bundle signaling element regions;
yellow, GTPase domain; dark green, stalk domain with L4 in light green). The position of positively selected sites is shown together with sequence
alignments for a few representative mammals. Positively selected sites are shown in red (sites identified in the whole phylogeny); primate- and pig-
specific sites are in orange and green, respectively. Gray vertical bars below the domain cartoon denote positively selected sites in MX1 (Mitchell et al.
2012). (B) Branch-site analysis of positive selection. Branch lengths are scaled to the expected number of substitutions per nucleotide, and branch colors
indicate the strength of selection (!). Red, positive selection (!> 5); blue, purifying selection (!= 0); and gray, neutral evolution (!= 1). The
proportion of each color represents the fraction of the sequence undergoing the corresponding class of selection. Thick branches indicate statistical
support for evolution under episodic diversifying selection as determined by BS-REL. Red dots denote branches that were also detected to be under
positive selection using the PAML branch-site models (after Bonferroni correction for multiple tests). (C) Structural model of the full-length MX2
protein predicted by I-TASSER. Positively selected sites identified in the whole phylogeny are in red, primate- and pig-specific sites are in orange and
green, respectively. Previously identified positively selected sites in the GTPase and stalk domains of MX1 are indicated in magenta. An enlargement of
loop 4 and part of the stalk domain is also shown (with rotation).
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and to exert a weak effect against vescicular stomatitis virus
infection (Liu et al. 2012). Specifically, the human and ma-
caque MX2 proteins efficiently restrict HIV-1 and other
simian immunodeficiency viruses, but have a modest effect
against retroviruses that infect nonprimate species such as
murine leukemia virus and feline immunodeficiency virus
(Goujon et al. 2013; Kane et al. 2013). This observation
points to species-specific virus–host interactions that may
result from evolutionary arms races (i.e., genetic conflicts be-
tween the host and the virus), a scenario previously described
for MX1 (Mitchell et al. 2012).
Herein, we analyze the evolutionary history of MX2 at the
inter- and intraspecific level and use this information to iden-
tify a haplotype that associates with natural resistance to HIV-
1 infection in humans.
Results
MX2 Evolutionary History in Mammals
To analyze the evolutionary history of MX2 in placental
mammals, we obtained coding sequence information for 29
species from public databases (supplementary table S1,
Supplementary Material online). Rodent gene sequences
were not included because of uncertain orthology (they
likely arose by duplication from an ancestral MX1-like gene)
(Verhelst et al. 2013). The multiple sequence alignment was
screened for recombination using Genetic Algorithm
Recombination Detection (GARD) (Kosakovsky Pond et al.
2006), which detected no breakpoint. The average nonsynon-
ymous substitution/synonymous substitution rate (dN/dS,
also known as!) for MX2 amounted to 0.39 (95% confidence
intervals [CIs]: 0.37–0.41), indicating a major role for purifying
selection (which leads to dN/dS values <1). However, al-
though constraints on protein function and structure often
result in purifying selection being the primary evolutionary
force acting on gene regions, diversifying selection (dN/dS
>1) might involve specific sites or domains. Indeed, this
has previously been shown to be the case for primate MX1
genes (Mitchell et al. 2012). To test this possibility, we applied
maximum Likelihood Ratio Test (LRT) statistics implemented
in the phylogenetic analysis by maximum likelihood (PAML)
package (Yang 1997, 2007). Specifically, we used the codeml
program to compare models of gene evolution that allow
(NSsite models M2a and M8, positive selection models) or
disallow (NSsite models M1a and M7, null models) a class of
codons to evolve with dN/dS>1. As reported in table 1, both
null models were rejected in favor of the positive selection
models; the same result was obtained using different codon
frequency models (F3x4 and F61) (table 1). Thus, MX2
evolved adaptively in placental mammals.
To identify specific sites subject to positive selection, we
applied the Bayes Empirical Bayes (BEB) method (with a cut-
off of 0.90) (Anisimova et al. 2002; Yang et al. 2005). Because
this approach may yield some false positives when a relatively
large number of sequences is analyzed (Kosakovsky Pond and
Frost 2005), we used the mixed-effects model of evolution
(MEME) (with the default cutoff of 0.1) (Murrell et al. 2012)
as a second criterion. To be conservative, only sites de-
tected by both methods were considered to be positively
selected, although this may result in an underestimation
of the actual number of selected sites. These analyses al-
lowed the identification of 11 positively selected sites in
MX2 (fig. 1A).
In order to explore possible variations in selective pressure
among different lineages, we first tested whether a model that
allows dN/dS to vary along branches (model M1) had signif-
icant better fit to the data than a model that assumes one
same dN/dS across the entire phylogeny (model M0) (Yang
and Nielsen 1998). This was indeed the case (table 1), indi-
cating that different mammals experienced variable levels of
selective pressure. We thus used the branch-site random-
effects likelihood (BS-REL) method (Kosakovsky Pond et al.
2011) to identify lineages on which a subset of sites have
evolved under positive selection. BS-REL makes no a priori
assumption about which lineages are more likely to represent
selection targets; the method identified three branches
(fig. 1B). These were cross-validated using the branch-site
models implemented in PAML (Zhang et al. 2005), which
apply a likelihood-ratio test to compare a model (MA) that
allows positive selection on one or more lineages (foreground
lineages) with a model (MA1) that does not allow such
positive selection (table 2). As suggested (Anisimova and
Yang 2007), a Bonferroni correction was applied to these
P values, as multiple hypotheses (three in this case) are
Table 1. Likelihood Ratio Test (LRT) Statistics for Models of Variable Selective Pressure among Sites and among Branches.
LRT Model Codon Frequency Model Degree of Freedom 2"ln La P Valueb Percentage of Sites with x >1 (average dN/dS)
M1a versus M2ac F3x4 2 67.83 1.86 1015 4.3% (2.79)
F61 2 34.83 2.73 108 3.4% (2.42)
M7 versus M8d F3x4 2 86.04 2.08 1019 7.9% (1.98)
F61 2 48.22 3.40 1011 10% (1.63)
M0 versus M1e F3x4 56 110.56 1.91 105 —
F61 56 99.00 3.5 104 —
aTwice the difference of the natural logs of the maximum likelihood of the models being compared.
bP value of rejecting the neutral models in favor of the positive selection models.
cM1a is a nearly neutral model that assumes one ! class between 0 and 1, and one class with != 1; M2a (positive selection model) is the same as M1a plus an extra class of
!> 1.
dM7 is a null model that assumes that 0<!< 1 is beta distributed among sites; M8 (positive selection model) is the same as M7 but also includes an extra category of sites
with !> 1.
eM0 and M1 are free-ratio models which assume all branches to have the same ! (M0) or allow each branch to have its own ! (M1).
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being tested on the same data set. PAML analysis confirmed
the three branches identified by BS-REL (table 2, fig. 1B). The
PAML branch-site models offer the possibility of identifying
specific sites that evolved under positive selection in the fore-
ground branches; this is achieved through implementation of
a BEB analysis (Zhang et al. 2005). Notably, the simultaneous
inference of both the site and the branch subject to diversi-
fying selection is difficult (Zhang et al. 2005; Murrell et al.
2012); thus, BEB analysis is accurate but has low power
(Zhang et al. 2005). Also, because identifying sites subject to
selection is more difficult than testing whether such sites
exist, the branch-site test may provide statistical support for
positive selection of the foreground branch(es), but BEB may
fail to detect sites with a posterior probability of >0.90
(Zhang et al. 2005). This is the case of the alpaca lineage:
We found evidence of episodic selection (fig. 1B and
table 2) but failed to identify the selected site(s).
Conversely, BEB detected one site in the primate and two
sites in the pig branches (fig. 1A). We reasoned that, because
MEME was specifically developed to detect episodic positive
selection (in addition to pervasive selection), lineage-specific
BEB sites should have been identified by the MEME analysis
we performed on the whole phylogeny. Indeed, the three sites
identified by BEB were also detected by MEME (fig. 1A). These
sites thus represent lineage-specific selection targets.
Structural Modeling and Analysis of MX2 Selected
Sites
As indicated above, analyses allowed identification of 11 MX2
sites subject to diversifying selection in the whole phylogeny;
five of these are located in an unstructured loop (loop 4),
where several positively selected sites were also detected in
primate MX1 genes (Mitchell et al. 2012) (fig. 1A). To gain
further insight into the functional role of positively selected
residues, we modeled the three-dimensional structure of MX2
using the known crystal structure of MX1 (63% identity at the
protein level) as a template. The use of I-TASSER (Roy et al.
2010) also allowed a reliable ab initio prediction of loop 4
structure (supplementary fig. S1, Supplementary Material
online), which includes two antiparallel alpha helices forming
a bump protruding from the stalk domain. Positively selected
sites in loop 4 form a continuous surface and are mainly
located on unstructured loops (fig. 1). Analysis of nonloop
4 selected sites in MX2 and comparison with MX1 selection
targets (Mitchell et al. 2012) indicated that the same region of
the stalk domain carries the MX2 460N residue and three
selected sites in MX1; also, the S518 residue is spatially close
to these residues (fig. 1C). Interestingly, the MX2 primate-
specific selection target in the GTPase domain (364S) is in
spatial proximity to a site subject to diversifying selection in
primate MX1 genes.
Evolution of MX1 and MX2 in the Human Lineage
We next applied a recently developed population genetics–
phylogenetics approach to study the evolution of MX1 and
MX2 in the human lineage. Specifically, we ran the
GammaMap program (Wilson et al. 2011) that jointly uses
intraspecific variation and interspecific diversity to estimate
the distribution of fitness effects (DFE) (i.e., selection coeffi-
cients, ) along coding regions. To this aim, we exploited data
from the 1000 Genomes Pilot project deriving from the low-
coverage whole genome sequencing of 179 individuals with
different ancestry: Europeans (CEU), Yoruba from Nigeria
(YRI), and Chinese plus Japanese (CHBJPT) (1000 Genomes
Project Consortium et al. 2010). The ancestral sequence was
reconstructed by parsimony from the human, chimpanzee,
orangutan, and macaque sequences. We first applied
GammaMap to obtain the overall distribution of selection
coefficients along MX1 and MX2. A general preponderance
of codons evolving under negative selection ( < 0) was ob-
served for both genes, with MX1 showing stronger constraint
(fig. 2). GammaMap allows to identify specific codons evolv-
ing under positive selection. We defined positively selected
codons as those having a cumulative probability >0.80 of
  1. None was found in either MX1 or MX2. Thus, coding
variants in the two genes did not represent positive selection
targets during human evolutionary history.
Population Genetic Analysis of MX2 in Humans
The results described above indicate that MX2 has been a
selection target throughout the evolutionary history of mam-
mals. In the human lineage, purifying selection had a major
role in shaping MX2 coding sequence diversity. Inspection of
the 1000 Genomes Project data indicated that one single
nonsynonymous variant in MX2 segregates in human popu-
lations at a frequency higher than 1% (rs56680307). This single
nucleotide polymorphism (SNP) is monomorphic or very rare
in non-African populations, whereas it has a minor allele
Table 2. Likelihood Ratio Test (LRT) Statistics for Models of Positive Selection on Specific Branches.
Foreground Brancha Codon Frequency Model Degree of Freedom 2"ln Lb P Valuec Bonferroni Corrected P Value
Primates F3x4 1 5.92 0.015 0.045
F61 1 5.84 0.016 0.048
Alpaca F3x4 1 31.52 1.97 108 5.91 1108
F61 1 30.90 2.7 1108 8.13 1108
Pig F3x4 1 139.05 4.29 11032 1.29 11031
F61 1 130.09 4.90 11030 1.20 11027
aMA and MA1 are branch-site models that assume four classes of sites: The MA model allows a proportion of codons to have ! 1 on the foreground branches (those to be
tested for selection), whereas the MA1 model does not.
b2ln L: Twice the difference of the natural logs of the maximum of the models being compared.
cP value of rejecting the neutral model in favor of the positive selection model.
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frequency (MAF) around 20% in Africa. We thus investigated
whether natural selection also affected genetic diversity at
MX2 in human populations acting either on rs56680307 or
on noncoding variants (as recent data have indicated that
regulatory polymorphisms represent the bulk of selection tar-
gets in human populations; Grossman et al. 2013; Forni et al.
2014). To this purpose, we initially exploited information from
the Human Genome Diversity Panel (HGDP), which consists
of approximately 650,000 SNPs genotyped in 52 populations
distributed worldwide (Li et al. 2008). Using these data, we
calculated FST among continental groups. FST is a measure of
population genetic differentiation: Under selective neutrality,
FST is mainly determined by demographic history and drift,
but natural selection may drive allele frequencies to differ
more than expected. Of 22 HGDP variants in MX2, three,
namely rs45430 (A/G), rs379839 (A/G), and rs2074560
(A/G), displayed an FST value higher than the 95th percentile
calculated from the distribution of HGDP variants in the same
MAF class (see Materials and Methods) (fig. 3). Analysis of
worldwide variation indicated that ancestral alleles for the
three SNPs are almost fixed in African populations, whereas
derived alleles reach high frequency outside Africa (fig. 4A).
Thus, selective sweeps may have occurred during human col-
onization of Eurasia and the Americas.
To investigate this possibility further, we used the 1000
Genomes Pilot Project genotype data. Selected variants
were searched for by integrating two approaches: One
based on population genetic differentiation and the other
on haplotype homozygosity. Thus, for all SNPs in MX2, we
calculated YRI–CEU and YRI–CHBJPT FST, as well as the
derived intra-allelic nucleotide diversity (DIND) test
(Barreiro et al. 2009) in CEU and CHBJPT. The rationale
behind the DIND test is that a derived allele under positive
selection will rapidly increase in frequency in the population
and will consequently display lower levels of nucleotide diver-
sity at linked sites than expected. Thus, the ratio of intra-allelic
diversity associated with the ancestral and derived alleles
(ipA/ipD) is analyzed against the frequency of the derived
allele (DAF); given a DAF interval, a high value of ipA/ipD
indicates that the neutral diversity associated with the derived
allele is limited, suggesting positive selection. DIND has higher
power than similar tests in most DAF ranges and is well suited
for low-coverage data (Barreiro et al. 2009; Fagny et al. 2014).
The statistical significance of both tests was obtained by de-
riving empirical distributions of the same parameters calcu-
lated for a large number of randomly selected genes (see
Materials and Methods).
In CEU 5, SNPs were outliers in the FST comparison (fig. 3)
and had a significant DIND test (DAF: 0.75–0.85, DIND: 4.9–
7.3). These variants include rs2074560 (derived allele: A) and,
despite the high recombination rate in the region, define a
homogeneous haplotype that carries derived alleles at several
SNPs (fig. 4B). In CHBJPT, two variants had a significantly high
FST value and a significant DIND test (rs28425 and rs443099,
DAF: 0.57 and 0.82, DIND: 7.99 and 7.1, respectively) (fig. 3). The
derived allele of rs443099 is carried by a group of homogeneous
haplotypes, a fraction of which also displays the derived allele
for rs28425 (fig. 4B). The rs45430 SNP, which we identified as
an outlier in the initial FST screen, has been associated with
melanoma susceptibility in a genome-wide association study
(GWAS); this variant is in tight linkage disequilibrium (LD)
(r2 = 0.95, D0 = 1) with rs443099, suggesting that the derived
allele, associated with increased melanoma risk, has swept to
high frequency outside Africa as a result of selection.
Overall, these results indicate that two distinct MX2 hap-
lotypes have been targeted by natural selection in Asian and
European populations.
Interestingly, ENCODE annotations (ENCODE Project
Consortium et al. 2012) deriving from experiments in
white blood cells or lymphoblastoid lineages indicated that
the CEU- and CHBJPT-selected variants are located in a large
region extending downstream the MX2 transcription start
site where several regulatory motifs are located, as assessed
by the analysis of DNase hypersensitive regions, transcription
factor binding sites, and histone modifications (fig. 4C).
FIG. 2. Lineage-specific selection and DFE analysis. Violin plot of selec-
tion coefficients (DFE) for MX1 and MX2 (median, white dot; interquar-
tile range, black bar). Selection coefficients () are classified as strongly
beneficial (100, 50), moderately beneficial (10, 5), weakly beneficial (1),
neutral (0), weakly deleterious (1), moderately deleterious (5, 10),
strongly deleterious (50, 100), and inviable (500).
FIG. 3. Population genetic differentiation. FST analysis of MX2 variants
for YRI–CEU (blue) and YRI–CHBJPT (red) comparisons. Lines represent
the 95th percentiles in each MAF class. Solid squares denote variants
identified in the HGDP SNP analysis (bold) or SNPs with a significant
DIND test.
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FIG. 4. Natural selection at MX2 in human populations. (A) Worldwide allele frequencies of the three HGDP variants showing outlier FST values. (B)
Schematic representation of CHBJPT plus YRI (left) and CEU plus YRI (right) haplotypes in the regions surrounding rs443099 and rs2074560, respec-
tively. Each line represents a haplotype, columns indicate polymorphic positions. Dark gray, derived alleles, light gray, ancestral alleles. The thick
horizontal line separates haplotypes carrying the ancestral (bottom) and derived (top) allele at the selected variants (rs443099 and rs2074560 in the left
and right panels, respectively). (C) Schematic representation of MX2 within the UCSC Genome Browser view. The location of the selection targets,
recombination rate (Kong et al. 2002), and relevant ENCODE tracks are also shown. SNP color codes are as in figure 3.
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MX2 Haplotype Association with HIV-1 Infection
Susceptibility
Given the recently described role of MX2 as a restriction
factor for HIV-1, we investigated whether the positively se-
lected European haplotype modulates susceptibility to HIV-1
infection. Most human subjects are susceptible to this virus,
but a minority of individuals do not seroconvert despite
multiple exposures. We thus genotyped rs2074560 (G/A) in
a cohort of 191 Spanish individuals who were exposed to the
virus through injection drug use (IDU). All of them were
hepatitis C virus (HCV) positive, but 85 tested HIV-1 negative
despite multiple exposures through needle sharing (HIV-
1-exposed seronegative, IDU-HESN); the remaining subjects
were HIV-1 positive (IDU-CTR). We observed a deviation
from Hardy–Weinberg equilibrium (HWE) in IDU-HESN
with an excess of homozygotes (HWE, P= 0.0047); IDU-CTR
complied to HWE. A significant difference was observed in
the genotypic distribution of rs2074560 in the two cohorts
(table 3), and the frequency of individuals homozygous for
the G allele was significantly higher in IDU-HESN (20.0%)
compared with IDU-CTR (7.5%). The odds ratio (OR) for a
recessive model with the GG genotype being protective
against HIV-1 infection was 3.06 (95% CI: 1.25–7.5; logistic
regression, P= 0.014). In order to replicate this finding, a
second HESN population with different geographic origin
and exposed to the virus through a different infection route
was analyzed as well. Thus, rs2074560 was genotyped in a
well-characterized cohort of 88 heterosexual Italian subjects
who have a history of unprotected sex with their seropositive
partners (sex-exposed HESN, SexExp-HESN). As a control, 188
Italian healthy controls (HCs) were genotyped; both samples
complied to HWE. Again, a significant difference was ob-
served in the genotype distribution of rs2074560 (logistic re-
gression, P= 0.014) (table 3); similarly to what was observed in
the Spanish sample, GG homozygotes were significantly
overrepresented in HESN (12.5%) compared with controls
(3.4%). Thus, a recessive model yielded a significant associa-
tion of the GG genotype with HIV-1 protection (logistic
regression, P= 0.005, OR: 4.33, 95% CI: 1.55–12.14). Further
confirmation was sought in a third and smaller population of
37 SexExp-HESN from Spain. These subjects are women who
exposed themselves repeatedly through unprotected inter-
course with their HIV-1-infected partners. A sample of 180
Spanish HC was also analyzed. The genotype proportions of
rs2074560 complied to HWE in both samples. Again, GG ho-
mozygotes were much more abundant among SexExp-HESN
(10.8%) than among HC (5.5%), thus supporting results ob-
tained in the two other case–control cohorts (table 3). As
expected, the small sample size of the HESN population re-
sulted in a nonsignificant P value due to lack of power. The
results of the three association analyses were combined
through a random-effect metaanalysis, which revealed no
heterogeneity among samples (Cochrane’s Q, P= 0.66,
I2 = 0) and yielded a P value of 1.55 104 (table 3).
Overall, these results strongly suggest that the G allele of
rs2074560 protects from HIV-1 with a recessive effect, irre-
spective of the infection route.
MX2 Haplotype Association with In Vitro Viral
Infection
To verify whether rs2074560 affects HIV-1 replication in vitro,
we performed an infection assay. Specifically, peripheral blood
mononuclear cells (PBMCs) from 50 Italian HESN subjects
were cultured and infected with HIV-1Ba-L. Viral replication
was assessed after 3 days by measuring viral p24 levels pro-
duced by the infected cells. Results indicated that the G allele
is associated with significantly lower p24 antigen levels
(Kruskal–Wallis rank-sum test, P= 0.034) (fig. 5).
MX2 Expression in Response to Interferon Treatment
Recent evidences have indicated that MX2 expression is in-
creased in response to inferon alpha (IFN-a) and that intrain-
dividual variability may exist in the level of induction (Goujon
et al. 2013; Kane et al. 2013). Thus, we assessed whether allelic
status at rs2074560 influences MX2 expression levels in
response to IFN-a. To this aim, PBMCs from 45 healthy vol-
unteers were stimulated with IFN-a and MX2 mRNA induc-
tion was evaluated by real-time polymerase chain reaction
(PCR). Results indicated that the G allele of rs2074560 is as-
sociated with a significantly increased MX2 expression in re-
sponse to IFN-a (Kruskal–Wallis rank-sum test, P= 0.033)
(fig. 6).
Discussion
The human MX2 protein has long been thought to lack
antiviral activity and to serve cellular functions such as
Table 3. Association of rs2074560 with HIV-1 Infection Susceptibility.
Sample Genotype Counts (GG/GA/AA) Pgenotypic
a Genotype Counts
(recessive)(GG/AG+AA)
Precessive
b OR (95% CI)c MetaAnalysis
Precessive and OR
d
HESN CTRe HESN CTR
IDU (Spain) 17/27/41 8/33/65 0.036 17/68 8/98 0.0143 3.06 (1.25–7.5)
HESN HC HESN HC 1.55 104
SexExp (Italy) 11/29/48 6/79/103 0.014 11/77 6/182 0.0052 4.33 (1.55–12.14) OR: 3.12
SexExp (Spain) 4/15/18 10/78/92 0.5078 4/33 10/170 0.24 2.06 (0.61–6.97)
aLogistic regression P value for a genotypic model.
bLogistic regression P value for a dominant model.
cOdds ratio for a recessive model with 95% CIs.
dRandom-effect metaanalysis P value (recessive model) and OR.
eIDU HIV-1 positive (IDU-CTR in the text).
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nucleocytoplasmic transport and cell-cycle progression
(King et al. 2004). Recent evidences have challenged this
view by showing that MX2 acts as a restriction factor
against HIV-1 and other simian retroviruses (Goujon et al.
2013; Kane et al. 2013; Liu, Pan, et al. 2013). Herein, we
follow-up on these observations and demonstrate that MX2
evolved adaptively in mammals and in human populations
and that a polymorphism in the gene modulates both MX2
expression in response to IFN-a and HIV-1 infection
susceptibility.
Antiviral effectors are known to represent common targets
of natural selection (Daugherty and Malik 2012), which most
likely ensues from host–pathogen genetic conflicts. Thus, de-
terminants of antiviral activity are often accounted for by
rapidly evolving residues. In primate MX1 genes, most sites
targeted by positive selection are located in loop 4 and explain
species-specific difference in antiviral activity against ortho-
myxoviruses, although additional determinants of antiviral
specificity must be accounted for by residues outside loop
4 (Mitchell et al. 2012). The natural selection pattern we ob-
served at MX2 closely reflects the one described for MX1, with
loop 4 strongly targeted by natural selection and the same
helix surface in the stalk domain carrying three positively
selected sites in MX1 and the positively selected 460 residue
in MX2 (Mitchell et al. 2012). Interestingly, one of the posi-
tively selected sites we identified in MX2, S518 in spatial prox-
imity to the 460 residue, corresponds to a polymorphic
position in the pig coding sequence; amino acid variation at
this residue modulate the ability of the porcine MX2 protein
to inhibit vescicular stomatitis virus replication (Sasaki et al.
2014), supporting the hypothesis that positively selected sites
determine antiviral activity.
Application of two different methods indicated that line-
age-specific selective events shaped diversity at primate MX2
genes. Currently available tests have limited power to simul-
taneously detect the sites and the lineages subject to episodic
positive selection (Zhang et al. 2005; Murrell et al. 2012).
Consequently, our analysis cannot be regarded as compre-
hensive in this respect, and additional sites evolving under
episodic selection may have gone undetected. Indeed, we
were unable to identify significant sites in the alpaca lineage,
and more sites may represent selection targets in primates
and pigs. Nonetheless, we consider that the sites we did iden-
tify are supported by robust evidence, as they were validated
by two distinct methods. Interestingly, one site evolving adap-
tively in primates is located in the MX2 GTPase domain, in
spatial proximity to an MX1 site positively selected in pri-
mates (Mitchell et al. 2012). These observations strongly sug-
gest that the GTPase domain might play a role as an antiviral
determinant, although its precise function needs further ex-
perimental analysis, as MX2 mutants unable to bind or hydro-
lyze GTP retain their anti-HIV-1 activity (Goujon et al. 2013;
Kane et al. 2013; Liu, Pan, et al. 2013). The role of loop 4
residues as antiviral determinants is more clearly established,
as single amino acid replacements alter the ability of MX1 to
restrict Thogoto virus and influenza A virus (Mitchell et al.
2012). A crystallographic study indicated that MX1 forms
ring-shaped oligomeric structures, but failed to solve the
structure of loop 4, which was however predicted to face
the internal surface of the ring (Gao et al. 2011). Our modeling
data indicate that MX2 loop 4 protrudes from the stalk back-
bone and, were MX2 to adopt the same conformation as
FIG. 5. Box-and-whisker plot of p24 antigen. PBMCs from 50 Italian
HESN subjects were infected with HIV-1Ba-L; the levels of viral p24
were measured after 3 days and normalized within experiments. Data
are shown as a function of rs2074560 genotype in standard box-and-
whisker plot representation (thick line, median; box, quartiles; whiskers,
1.5 interquartile range).
FIG. 6. Box-and-whisker plot of MX2 induction in response to IFN-a.
Data derive from IFN-a stimulation of PBMCs deriving from 45 healthy
volunteers. MX2 transcript levels are shown as log-transformed fold-
change expression from the unstimulated sample. Data are shown in
standard box-and-whisker plot representation, as in figure 5.
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MX1 oligomers, might act as the foremost contact surface
with the viral substrate (the capsid protein in the case of
HIV-1; Goujon et al. 2013; Kane et al. 2013; Liu, Pan, et al.
2013).
Results herein also indicate a continuum in selective pres-
sure acting in mammals and in human populations, and tar-
geting MX2. Nonetheless, in line with a large-scale analysis of
positive selection, which revealed most human selection tar-
gets to be located in noncoding regions (Grossman et al.
2013), positive selection acted on MX2 SNPs with a likely
regulatory role, whereas the coding sequence was mainly
subject to selective constraint in the human lineage.
Population genetic analyses indicate that two different hap-
lotypes swept to high frequency in the populations of non-
African ancestry; in both cases the result is counter intuitive as
selection favored the frequency increase of a melanoma sus-
ceptibility allele and of a polymorphism/haplotype associated
with decreased IFN-a induction and augmented HIV-1 infec-
tion susceptibility. Previous analyses have indicated that risk
alleles for human diseases may represent selection targets
(Fumagalli et al. 2009; Zhernakova et al. 2010; Jostins et al.
2012; Raj et al. 2012; Forni et al. 2013) and this possibly reflects
either changes in environmental pressures or pleiotropic ef-
fects of the selected alleles. Thus, the variant we analyzed may
differently affect IFN-a response in cell types other than
PBMCs. Indeed, rs2074560 is located in a region which likely
modulates transcriptional activity in different cell types, as
suggested by the presence of DNaseI hypersensitivity peaks
and transcription factor binding sites. An alternative explana-
tion is that increased levels of MX2 induction in response to
IFN-a is deleterious to some cellular process unrelated to
antiviral response, an hypothesis previously proposed to ex-
plain the loss of APOBEC3H activity in the populations of
non-African ancestry (OhAinle et al. 2008). Conversely, our
data indicate that the stronger response to IFN-a afforded by
the rs2074560 ancestral allele confers protection in the con-
text of HIV-1 infection. Indeed, we analyzed three populations
of HESN subjects with different geographic origin and distinct
routes of exposure to the virus. Results were consistent in
showing that homozygosity for the G allele at rs2074560 pro-
tects from infection. Because association results were repli-
cated in the three independent cohorts, we consider that
evidences are strong enough to establish a role for
rs2074560 as a determinant of HIV-1 infection susceptibility
in humans, despite the relatively small sample of the HESN
populations. Moreover, the association results are supported
by the in vitro infection assay, which indicated that the
G allele significantly decreases viral replication. Recently,
Lane et al. (2013) performed a GWAS of resistance to HIV-1
infection in highly exposed uninfected hemophiliacs and
detected no genome-wide significant association with the
exclusion of the known CCR5D32 allele; nonetheless, given
the average MAF of rs2074560 in Europeans (around 0.25), its
recessive effect, and the OR estimated herein (OR: 3.12), their
study was underpowered to reach genome-wide significance
for this variant.
A recent study of HIV-1-infected and seronegative subjects
confirmed that CCR5D32 homozygotes are protected from
infection (OR = 0.2), whereas no effect was detected for the
HLA-B*57:01 and *27:05 alleles, both associated with slow pro-
gression to AIDS (McLaren et al. 2013). The CCR5D32 allele is
almost exclusively found in Europe and West Asia, where its
frequency follows a latitudinal cline (Novembre et al. 2005). In
Italy and Spain, the estimated frequency of CCR5D32 homo-
zygotes is around 0.25–0.5% (Novembre et al. 2005), indicat-
ing that this allele makes a minor contribution to HIV-1
susceptibility at the population level. Additional polymor-
phisms that modulate the susceptibility to HIV-1 infection
have been identified in recent years; all of them map to genes
involved directly (e.g., ERAP2, IRF1, and TLR3) or indirectly
(FREM1 and CYP7B1) in immune response (Ball et al. 2007;
Limou et al. 2012; Luo et al. 2012; Sironi et al. 2012; Biasin et al.
2013). Some of these loci showed a relatively strong effect,
comparable to that estimated for the MX2 variants we de-
scribe herein (Ball et al. 2007; Limou et al. 2012; Luo et al. 2012;
Biasin et al. 2013). Nonetheless, most of these analyses, in-
cluding those reported in our study, were performed on rel-
atively small population samples, because of the intrinsic
difficulty in characterizing and recruiting HESN cohorts.
Thus, calculation of the effect size on lager samples will be
necessary to provide more reliable estimations.
Another point that will require further investigation is the
reason(s) why rs2074560, which modulates expression levels,
confers protection with a recessive effect. One possibility is
that the cellular amount of MX2 protein is rate limiting for
efficient HIV-1 restriction, so that a threshold needs to be
reached to afford in vivo protection. This model might be
appealing in light of the proposed model for MX1 antiviral
activity, whereby oligomers enclose and sequester viral com-
ponents (Reichelt et al. 2004; Gao et al. 2011). Another pos-
sibility is that, although in the association analysis infection
susceptibility was treated as a dichotomous variable (i.e.,
HESN/non-HESN status), it may be a continuous trait. Thus,
the HESN status possibly represents an extreme phenotype
and selection of HESN cohorts may result in enrichment for
the most protective genotype. This hypothesis is in line with
the results from the in vitro infection assay, whereby
rs2074560 genotype was analyzed against a continuous vari-
able (p24 antigen levels); in this experiment, the effect of the
G allele was also evident in heterozygous subjects, and the
limited number of GG homozygotes makes it difficult to de-
termine whether an additive model applies to these data.
The observation that the MX2 polymorphism that modu-
lates susceptibility to HIV-1 infection also regulates MX2
expression in response to IFN-a is biologically interesting.
MX2 is part of the interferon-regulated genes, a vast and
heterogeneous family of genes whose expression is modulated
by IFN-a. Some of these genes, including CH25H, were re-
cently shown to be endowed with potent antiviral properties
(Liu, Aliyari, et al. 2013). It is thus tempting to envision a
scenario in which an initial infection with HIV-1 of target
cells that are GG homozygous would trigger the upregulation
of MX2; this in turn would block viral replication and impede
nuclear accumulation and chromosomal integration of
nascent viral DNA. The infection would be aborted and the
immune response would be able to clear away the few cells
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that had been initially infected, preventing the infection to
spread in an uncontrolled fashion. This could explain the
puzzling presence of HIV-specific T helper cells and CTL in
the absence of any detectable ongoing infection: A phenom-
enon that is observed in HESN not only during, but, tran-
siently, also after cessation of exposure (Miyazawa et al. 2009).
In summary, building on the recently described role of
MX2 as HIV-1 restriction factors, we exploited evolutionary
information to identify a variant that confers natural resis-
tance to HIV-1 infection. Results herein establish the role of
MX2 as a central element of antiviral response in mammalian
species and a possible target for therapeutic intervention in
HIV-1 treatment and prevention.
Materials and Methods
Evolutionary Analysis in Mammals
Mammalian sequences for MX2 were retrieved from the
Ensembl and NCBI databases (http://www.ensembl.org/
index.html; http://www.ncbi.nlm.nih.gov/, last accessed
December 2013). The list of species is reported in supplemen-
tary table S1, Supplementary Material online. DNA align-
ments were performed using the RevTrans 2.0 utility
(Wernersson and Pedersen 2003), which uses the protein se-
quence alignment as a scaffold to construct the correspond-
ing DNA multiple alignment. This latter was checked and
edited by hand to remove alignment uncertainties. For
PAML analyses (Yang 2007), we used trees generated by max-
imum likelihood using the program PhyML (Guindon et al.
2009).
The site models implemented in PAML have been devel-
oped to detect positive selection affecting only a few amino
acid residues in a protein. To detect selection, site models that
allow (M2a, M8) or disallow (M1a, M7) a class of sites to
evolve with ! >1 were fitted to the data using the F3x4
and the F61 codon frequency model. Positively selected
sites were identified using the BEB analysis (with a cutoff of
0.90), which calculates the posterior probability that each
codon is from the site class of positive selection (under
model M8) (Anisimova et al. 2002). A second method, the
MEME (with the default cutoff of 0.1) (Murrell et al. 2012),
was applied to identify positively selected sites. MEME allows
the distribution of! to vary from site to site and from branch
to branch at a site, therefore allowing the detection of both
pervasive and episodic positive selection (Murrell et al. 2012).
To explore possible variations in selective pressure among
different lineages, we applied the free-ratio models imple-
mented in the PAML package: The M0 model assumes all
branches to have the same!, whereas M1 allows each branch
to have its own ! (Yang and Nielsen 1998). The models are
compared through likelihood-ratio tests (degree of free-
dom = total number of branches 1). In order to identify
specific branches with a proportion of sites evolving with
!> 1, we used BS-REL (Kosakovsky Pond et al. 2011) with
the PhyML-generated tree. Branches identified using this ap-
proach were cross-validated with the branch-site likelihood-
ratio tests from PAML (the so-called modified model A and
model MA1, “test 2”) (Zhang et al. 2005). A Bonferroni
correction was applied to account for multiple hypothesis
testing (i.e., we corrected for the number of tested lineages),
as suggested (Anisimova and Yang 2007). The advantage of
this method is that it also implements a BEB analysis analo-
gous to that described above to calculate the posterior prob-
abilities that each site belongs to the site class of positive
selection on the foreground lineages. Thus, BEB allows iden-
tification of specific sites that evolve under positive selection
on specific lineages, although it has limited statistical power
(Zhang et al. 2005).
GARD (Kosakovsky Pond et al. 2006), MEME (Murrell et al.
2012), and BS-REL analyses were performed through the
DataMonkey server (Delport et al. 2010) (http://www.data
monkey.org, last accessed December 2013).
Structural Model Prediction and Validation
Structural models of MX2 were initially predicted using three
different methods: MODELLER (Eswar et al. 2006) with loop
refinement, I-TASSER (Zhang 2008; Roy et al. 2010) with a
defined template (MX1, PDB structure: 3SZR; Gao et al. 2011),
or I-TASSER without any template. The quality of each
model was assessed with VADAR (Willard et al. 2003). The
overall quality was estimated with respect to its geometry and
energy (packaging defects, free energy of folding, core hydro-
phobic and charged residues) (supplementary table S2, Sup-
plementary Material online). Secondary structures found in
loops were validated through the use of PSIPRED (McGuffin
et al. 2000) server (supplementary fig. S1, Supplementary
Material online). According to these criteria, the model pro-
duced by I-TASSER with MX1 as template was used for our
analysis.
Population Genetics–Phylogenetics Analysis
Data from the Pilot 1 phase of the 1000 Genomes Project
were retrieved from the dedicated Website (1000 Genomes
Project Consortium et al. 2010). Low-coverage SNP genotypes
were organized in a MySQL database. A set of programs was
developed to retrieve genotypes from the database and to
analyze them according to selected regions/populations.
These programs were developed in C++ using the GeCo++
(Cereda et al. 2011), the libsequence (Thornton 2003), and the
mysqlpp libraries. Coding sequence information was obtained
for MX1 and MX2. To analyze the DFE, we used GammaMap
(Wilson et al. 2011). We assumed  (neutral mutation rate per
site), k (transitions/transversions ratio), and T (branch length)
to vary among genes following log-normal distributions. For
each gene, we set the neutral frequencies of non-STOP
codons (1/61) and the probability that adjacent codons
share the same selection coefficient (P= 0.02). For selection
coefficients, we considered a uniform Dirichlet distribution
with the same prior weight for each selection class. For each
gene, we run 10,000 iterations with thinning interval of ten
iterations.
Population Genetic Analysis in Humans
HGDP genotype data derive from a previous work (Li et al.
2008). Atypical or duplicated samples and pairs of close
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relatives were removed (Rosenberg 2006). FST among conti-
nental groups was calculated for all HGDP SNPs. Because FST
values are not independent from allele frequencies, variants
were divided in 100 percentile classes based on MAF and FST
distributions were calculated for each class; outliers were de-
fined as variants with an FST higher than the 95th percentile in
the distribution of SNPs in the same MAF class.
Data from the Pilot 1 phase of the 1000 Genomes Project
were retrieved as described above. Genotype information
was obtained for MX2 and for 1,200 randomly selected
RefSeq genes. Orthologous regions in the chimpanzee,
orangutan, or macaque genomes (outgroups) were retrieved
using the liftOver tool (http://hgdownload.cse.ucsc.edu/,
last accessed December 2013); genes showing less than
80% human–outgroup aligning bases were discarded. This
originated a final set of 987 genes (control set). FST (Wright
1950) and the DIND test (Barreiro et al. 2009) were calcu-
lated for all SNPs mapping to MX2 and to the control gene
sets. For FST variants were binned variants based on their
MAF (100 classes) and the 95th percentile for each MAF
class was calculated. As for the DIND test, it was originally
developed for application to Sanger or high-coverage se-
quencing data (Barreiro et al. 2009), so that statistical signif-
icance can be inferred through coalescent simulations. This
is not the case for the 1000 Genomes Project data; thus, we
calculated statistical significance by obtaining an empirical
distribution of DIND–DAF value pairs for variants located
within control genes. Specifically, DIND values were calcu-
lated for all SNPs using a constant number of 40 flanking
variants (20 up- and downstream). The distributions of
DIND–DAF pairs for YRI, CEU, and CHBJPT were binned
in DAF intervals (100 classes, bin = 0.01) and for each class
the 95th percentile was calculated. As suggested (Barreiro
et al. 2009), for values of ipD= 0, we set the DIND value to
the maximum obtained over the whole data set plus 20.
Subject Cohorts, Genotyping, and Statistical Analysis
We recruited 191 males exposed to HIV-1 infection by IDU
and enrolled in prospective cohort studies in Spain (Valme
Hospital, Sevilla) who had shared needles for >3 months.
Concurrent markers of HCV infection were present in 100%
of IDU subjects. Eighty-five of these subjects were HIV-1 neg-
ative (IDU-HESN) and 106 were HIV-1 positive (IDU-CTR).
Thirty-eight Spanish HESN exposed to the virus through
unprotected sexual intercourse (SexExp-HESN) were also
recruited. These subjects are female partners of HIV-1 pos-
itive patients (without treatment and viremic, mean
number of unprotected sexual intercourse per year: 110,
mean number of years as sexual partners: 5, range 3–17).
HCs (n= 180) that were anonymous blood donors from The
City of Jaen Hospital were also recruited. All these individuals
were seronegative for both HIV-1 and HCV. All subjects were
Spanish of Caucasian origin. The study was designed and
performed according to the Helsinki declaration and was
approved by the Ethics Committee of the participating hos-
pitals and the University of Jaen. All patients and healthy
blood donors provided written informed consent to partic-
ipate in this study.
As for Italian SexExp-HESN, inclusion criteria were a history
of multiple unprotected sexual episodes for more than 4 years
at the time of enrolment, with at least three episodes of at-risk
intercourse within 4 months prior to study entry and an
average of 30 (range, 18 to >100) reported unprotected
sexual contacts per year (Miyazawa et al. 2009). SexExp-
HESN and 188 HCs were recruited at the S. M. Annunziata
Hospital, Florence; all of them were Italian of Caucasian origin.
The study was reviewed and approved by the institutional
review board of the S. M. Annunziata Hospital, Florence.
Written informed consent was obtained from all subjects.
rs2074560 was genotyped through PCR amplification
and direct sequencing (primer sequences are available upon
request). PCR products were treated with ExoSAP-IT (USB
Corporation, Cleveland OH), directly sequenced on both
strands with a Big Dye Terminator sequencing Kit version
3.1 (Applied Biosystems), and run on an Applied Biosystems
ABI 3130 XL Genetic Analyzer (Applied Biosystems).
Sequences were assembled using AutoAssembler version
1.4.0 (Applied Biosystems), and inspected manually by two
distinct operators. Genetic association analyses were
performed by logistic regression and results from the three
cohorts were combined using a random-effect metaanaly-
sis; all analyses were performed using PLINK (Purcell et al.
2007).
HIV Infection Assay
PBMCs from 50 HESN subjects were separated on lympho-
cyte separation medium (Organon Teknica, Malvern, PA);
10 106 cells/ml were cultured for 2 days at 37 C and 5%
CO2 in RPMI 1640 containing FBS (20%), phytohemagglutinin
(7.5mg/ml), and interleukin-2 (IL-2) (15 ng/ml). After viability
assessment, 2.5 106 cells were resuspended in medium con-
taining 1 ng of HIV-1Ba-L p24 viral input/10
6 PBMC and incu-
bated for 3 h at 37 C. Cells were then washed and
resuspended in 3 ml of complete medium with IL-2 (15 ng/
ml). Cells were plated in 24-well tissue culture plates and
incubated at 37 C and 5% CO2. After 3 days supernatants
were collected for p24 antigen enzyme-linked immunosor-
bent assay (ELISA) analyses. Absolute levels of p24 were mea-
sured using the Alliance HIV-1 p24 ELISA Kit (PerkinElmer).
PBMCs from the 50 subjects were split and infected in three
independent experiments. To account for minor differences
in virus titer, p24 levels were normalized within experiment.
HIV-1Ba-L was provided through the EU programme EVA
centre for AIDS Reagents NIBSC, UK.
IFN-a Stimulation and MX2 Transcript Quantification
Whole blood was collected from 45 HCs by venupuncture in
Vacutainer tubes containing EDTA (Becton Dickinson, NJ),
and PBMCs were separated on lymphocyte separation
medium (Organon Teknica, Malvern, PA). Based on data
derived from a kinetic study (data not shown), 5 105
freshly isolated PBMCs were incubated for 3 h with
medium alone or 400 U/ml IFN-a (Sigma Aldrich).
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RNA was extracted from cultured PBMC by using the acid
guanidium thiocyanate–phenol–chloroform method. The
RNA was dissolved in RNase-free water, and purified from
genomic DNA with RNase-free DNase (RQ1 DNase; Promega,
Madison, WI). One microgram of RNA was reverse tran-
scribed into first-strand cDNA in a 20thinsp;-ml final
volume containing 1mM random hexanucleotide primers,
1mM oligo dT, and 200 U Moloney murine leukemia virus
reverse transcriptase (Clontech, Palo Alto, CA). cDNA quan-
tification for MX2 and GAPDH was performed by a real-time
PCR strategy (DNA Engine Opticon 2; MJ Research, Ramsey,
MN). Reactions were performed using a SYBR Green PCR mix
(5 Prime, Gaithersburg, MD). Results were expressed asCt
and presented as ratios between the target gene and the
GAPDH housekeeping mRNA.
Supplementary Material
Supplementary figure S1 and tables S1 and S2 are available at
Molecular Biology and Evolution online (http://www.mbe.
oxfordjournals.org/).
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